1. Non-coding RNAs in the reprogramming of glucose metabolism in cancer
   Ram C. Shankaraiah et al, 2018, Cancer Letters CrossRef
2. The Role of Long Non-Coding RNAs in Hepatocarcinogenesis
   Manuela Lanzafame et al, 2018, IJMS CrossRef
3. The emerging co-regulatory role of long noncoding RNAs in epithelial-mesenchymal transition and the Warburg effect in aggressive tumors
   Qian Hua et al, 2018, Critical Reviews in Oncology/Hematology CrossRef
4. A Systematic Review of Long Noncoding RNAs in Hepatocellular Carcinoma: Molecular Mechanism and Clinical Implications
   Xiaoge Hu et al, 2018, BioMed Research International CrossRef
5. Caveolin enhances hepatocellular carcinoma cell metabolism, migration, and invasion in vitro via a hexokinase 2-dependent mechanism
   Fang Chai et al, 2018, J Cell Physiol CrossRef
6. Long non-coding RNAs involved in cancer metabolic reprogramming
   Hui Liu et al, 2018, Cell. Mol. Life Sci. CrossRef
7. Long non-coding RNA PVT1 promotes autophagy as ceRNA to target ATG3 by sponging microRNA-365 in hepatocellular carcinoma.
   Liang Yang et al, 2019, Gene CrossRef
8. Regulatory roles of long noncoding RNAs implicated in cancer hallmarks.
   Jun Wang et al, 2020, Int J Cancer CrossRef
9. Glut 1 in Cancer Cells and the Inhibitory Action of Resveratrol as A Potential Therapeutic Strategy.
   Angara Zambrano et al, 2019, Int J Mol Sci CrossRef
10. Molecular mechanisms of circular RNAs, transforming growth factor‐ β , and long noncoding RNAs in hepatocellular carcinoma
    Wenkang Shang et al, 2019, Cancer Med CrossRef
11. Regulation of mTOR signaling by long non-coding RNA
    Karam Aboudehen, 2019, Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms CrossRef
12. LncRNAs: The Regulator of Glucose and Lipid Metabolism in Tumor Cells
    Wei Lu et al, 2019, Front. Oncol. CrossRef
13. LncRNA HOTAIR knockdown inhibits glycolysis by regulating miR-130a-3p/HIF1A in hepatocellular carcinoma under hypoxia
    Mingxing Hu et al, 2020, Biomedicine & Pharmacotherapy CrossRef
14. HIF1A activates the transcription of lncRNA RAET1K to modulate hypoxia-induced glycolysis in hepatocellular carcinoma cells via miR-100-5p
    Yufan Zhou et al, 2020, Cell Death Dis CrossRef
15. Crosstalk of lncRNA and Cellular Metabolism and Their Regulatory Mechanism in Cancer.
    Yang-Hsiang Lin, 2020, Int J Mol Sci CrossRef
16. Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma.
    Jiao Feng et al, 2020, J Exp Clin Cancer Res CrossRef
17. Does nutrition for cancer patients feed the tumour? A clinical perspective
    F. Bozzetti et al, 2020, Critical Reviews in Oncology/Hematology CrossRef
18. Long non‑coding RNAs in HBV‑related hepatocellular carcinoma (Review)
    Hao Zhang et al, 2019, Int J Oncol CrossRef
19. Long non-coding RNA KCNQ1OT1 mediates the growth of hepatocellular carcinoma by functioning as a competing endogenous RNA of miR-504
    Chao Li et al, 2018, Int J Oncol CrossRef
20. Downregulation of lncRNA AWPPH inhibits colon cancer cell proliferation by downregulating GLUT‑1
    Jie Bai et al, 2019, Oncol Lett CrossRef
21. Regulation of Glucose and Lipid Metabolism by Long Non-coding RNAs: Facts and Research Progress
    Tie-Ning Zhang et al, 2020, Front. Endocrinol. CrossRef
22. PI3K/AKT/mTOR pathway-related long non-coding RNAs: roles and mechanisms in hepatocellular carcinoma.
    Yuting Wu et al, 2020, Pharmacol Res CrossRef
23. Long non-coding RNA Gm15441 attenuates hepatic inflammasome activation in response to PPARA agonism and fasting
    Chad N. Brocker et al, 2020, Nat Commun CrossRef
24. LncRNA HOTAIR regulates glucose transporter Glut1 expression and glucose uptake in macrophages during inflammation
    Monira Obaid et al, 2021, Sci Rep CrossRef
25. Exosomal Long Non-coding RNAs: Emerging Players in the Tumor Microenvironment
    Anup S. Pathania et al, 2020, Molecular Therapy - Nucleic Acids CrossRef
26. Glycolysis-associated lncRNAs identify a subgroup of cancer patients with poor prognoses and a high-infiltration immune microenvironment
    Kuo-Hao Ho et al, 2021, BMC Med CrossRef
27. Involvement of Long Non-Coding RNAs in Glucose Metabolism in Cancer
    Amar Balihodzic et al, 2021, Cancers CrossRef
28. LncRNA NBR2 aggravates hepatoblastoma cell malignancy and promotes cell proliferation under glucose starvation through the miR-22/TCF7 axis
    Chengguang Zhu et al, 2021, Cell Cycle CrossRef
29. Long non-coding RNA-based glycolysis-targeted cancer therapy: feasibility, progression and limitations
    Rui Liu et al, 2021, Mol Biol Rep CrossRef
30. Towards decoding the coupled decision-making of metabolism and epithelial-to-mesenchymal transition in cancer
    Dongya Jia et al, 2021, Br J Cancer CrossRef
31. The emerging regulatory roles of long non-coding RNAs implicated in cancer metabolism
    Yongcan Xu et al, 2021, Molecular Therapy CrossRef
32. Mechanism, Clinical Significance, and Treatment Strategy of Warburg Effect in Hepatocellular Carcinoma
    Hui Chen et al, 2021, Journal of Nanomaterials CrossRef
33. Epigenetic Regulation of Hepatocellular Carcinoma Progression through the mTOR Signaling Pathway
    Mengnan Guo et al, 2021, Canadian Journal of Gastroenterology and Hepatology CrossRef
34. lncRNA GAS6-AS1 inhibits progression and glucose metabolism reprogramming in LUAD via repressing E2F1-mediated transcription of GLUT1.
    Jing Luo et al, 2021, Mol Ther Nucleic Acids CrossRef
35. Epigenomic and Metabolomic Integration Reveals Dynamic Metabolic Regulation in Bladder Cancer
    Alba Loras et al, 2021, Cancers CrossRef
36. Novel Hypoxia-Related Gene Signature for Risk Stratification and Prognosis in Hepatocellular Carcinoma
    Quanxiao Li et al, 2021, Front. Genet. CrossRef
37. Research Status and Prospect of Metabolic Abnormalities in Hepatocellular Carcinoma
    峰 祁, 2021, ACM CrossRef
38. Targeting Long Non-Coding RNAs in Hepatocellular Carcinoma: Progress and Prospects
    Xinrong Lin et al, 2021, Front. Oncol. CrossRef
39. Integrated analysis of Solute carrier family-2 members reveals SLC2A4 as an independent favorable prognostic biomarker for breast cancer
    Zhenyu Shi et al, 2021, Channels CrossRef
40. The Epithelial–Mesenchymal Transition at the Crossroads between Metabolism and Tumor Progression
    Monica Fedele et al, 2022, IJMS CrossRef
41. Progress of HOTAIR-microRNA in hepatocellular carcinoma
    Bing-rong Wang et al, 2022, Hered Cancer Clin Pract CrossRef
42. Association of Polymorphisms within HOX Transcript Antisense RNA (HOTAIR) with Type 2 Diabetes Mellitus and Laboratory Characteristics: A Preliminary Case-Control Study
    Saman Sargazi et al, 2022, Disease Markers CrossRef
43. Lactate: The Mediator of Metabolism and Immunosuppression.
    Yuanyuan Zhang et al, 2022, Front Endocrinol (Lausanne) CrossRef
44. Long non-coding RNA HOTAIR regulates cytoskeleton remodeling and lipid storage capacity during adipogenesis
    Evdokiia Potolitsyna et al, 2022, Sci Rep CrossRef
45. Long non-coding RNAs play an important regulatory role in tumorigenesis and tumor progression through aerobic glycolysis
    Ni Fan et al, 2022, Front. Mol. Biosci. CrossRef
46. Advancing in Schaaf-Yang syndrome pathophysiology: from bedside to subcellular analyses of truncated MAGEL2
    Laura Castilla-Vallmanya et al, 2022, J Med Genet CrossRef
47. Research progress on the interaction between long non‑coding RNAs and RNA‑binding proteins to influence the reprogramming of tumor glucose metabolism (Review)
    Weizheng Wu et al, 2022, Oncol Rep CrossRef
48. Interactome battling of lncRNA CCDC144NL-AS1: Its role in the emergence and ferocity of cancer and beyond
    Yasmine K. Abd El Fattah et al, 2022, International Journal of Biological Macromolecules CrossRef
49. Regulation of Tumor Metabolome by Long Non-Coding RNAs
    Revathy Nadhan et al, 2022 CrossRef
50. null
    Jack He et al, 2022 CrossRef
51. Comprehensive analysis of immune subtypes reveals the prognostic value of cytotoxicity and FAP+ fibroblasts in stomach adenocarcinoma
    Xin Wang et al, 2023, Cancer Immunol Immunother CrossRef
52. Making Sense of Antisense lncRNAs in Hepatocellular Carcinoma
    Nicola Mosca et al, 2023, IJMS CrossRef
53. Decoding hepatocarcinogenesis from a noncoding RNAs perspective
    Mostafa K. Abd El‐Aziz et al, 2023, Journal Cellular Physiology CrossRef
54. Differentially expressed non-coding RNAs and their regulatory networks in liver cancer
    Nurbubu T. Moldogazieva et al, 2023, Heliyon CrossRef
55. Brassica oleracea L. extract ameliorates isoproterenol-induced myocardial injury by regulating HIF-1α-mediated glycolysis
    Huiling Luan et al, 2024, Fitoterapia CrossRef
56. From Carcinogenesis to Therapeutic Avenues: lncRNAs and mTOR Crosstalk in Lung Cancer
    Md Sadique Hussain et al, 2023, Pathology - Research and Practice CrossRef
57. Molecular Signaling and Metabolic Responses during the Interaction between Human Keratinocytes (HaCaT) and the Dermatophyte Trichophyton rubrum
    Monise Fazolin Petrucelli et al, 2024, JoF CrossRef
58. Human mtDNA-Encoded Long ncRNAs: Knotty Molecules and Complex Functions
    Francesco Bruni, 2024, IJMS CrossRef
59. The role of long non-coding RNA in hepatocellular carcinoma
    Weizheng Liang et al, 2024, Aging CrossRef
60. ASACO: Automatic and Serial Analysis of CO-expression to discover gene modifiers with potential use in drug repurposing
    Cristina Moral-Turón et al, 2024 CrossRef
61. Biological roles of SLC16A1-AS1 lncRNA and its clinical impacts in tumors
    Bing Liao et al, 2024, Cancer Cell Int CrossRef
62. Non-Coding RNA Mediated Regulation of PI3K/Akt Pathway in Hepatocellular Carcinoma: Therapeutic Perspectives
    Md Sadique Hussain et al, 2024, Pathology - Research and Practice CrossRef
63. Involvement of lncRNAs in the regulation of aerobic glycolysis in hepatocellular carcinoma: Main functions, regulatory mechanisms and potential therapeutic implications (Review)
    Qiongqing Huang et al, 2024, Oncol Rep CrossRef
64. Phytochemical analysis and cardiovascular protective effect of four herbal medicines with functional food properties ( Four Huaiqing Chinese Medicine )
    Yan Li et al, 2024, Natural Product Research CrossRef